These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 32221079)

  • 21. Development and Validation of Nomograms Predicting Overall and Cancer-Specific Survival of Spinal Chondrosarcoma Patients.
    Song K; Song J; Shi X; Wang H; Ma X; Xia X; Liang X; Lin K; Jiang J
    Spine (Phila Pa 1976); 2018 Nov; 43(21):E1281-E1289. PubMed ID: 29664813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Establishment and validation of nomograms to predict the overall survival and cancer-specific survival for non-metastatic bladder cancer patients: A large population-based cohort study and external validation.
    Li S; Wang J; Zhang Z; Wu Y; Liu Z; Yin Z; Liu J; He D
    Medicine (Baltimore); 2024 Mar; 103(11):e37492. PubMed ID: 38489693
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development and validation of prognostic nomograms for pseudomyxoma peritonei patients after surgery: A population-based study.
    Chen P; Su L; Yang W; Zhang J; Wang Y; Wang C; Yu Y; Yang L; Zhou Z
    Medicine (Baltimore); 2020 Jul; 99(31):e20963. PubMed ID: 32756083
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nomograms to predict survival of stage IV tongue squamous cell carcinoma after surgery.
    Sun W; Cheng M; Zhuang S; Chen H; Yang S; Qiu Z
    Medicine (Baltimore); 2019 Jun; 98(26):e16206. PubMed ID: 31261568
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic nomograms and Aggtrmmns scoring system for predicting overall survival and cancer-specific survival of patients with kidney cancer.
    Zhou Y; Zhang R; Ding Y; Wang Z; Yang C; Tao S; Liang C
    Cancer Med; 2020 Apr; 9(8):2710-2722. PubMed ID: 32087609
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and validation of prognostic nomograms for patients with colon neuroendocrine neoplasms.
    Xu R; Zhou B; Hu P; Xue B; Gu D; Li X; Tang Q
    World J Surg Oncol; 2021 Aug; 19(1):233. PubMed ID: 34364382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Prognostic Model for Patients With Gastric Signet Ring Cell Carcinoma.
    Guo Q; Wang Y; An J; Wang S; Dong X; Zhao H
    Technol Cancer Res Treat; 2021; 20():15330338211027912. PubMed ID: 34190015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic model for predicting overall and cancer-specific survival among patients with superficial spreading melanoma: A SEER based study.
    Ji Q; Tang J; Li S; Chen J
    Medicine (Baltimore); 2022 Dec; 101(52):e32521. PubMed ID: 36596029
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nomograms for predicting the overall and cancer-specific survival in patients with non-urothelial carcinoma of the bladder: A population-based study.
    Li Z; Xu Z; Wang J; Wang M
    Biomol Biomed; 2024 May; 24(3):633-646. PubMed ID: 38041686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Clinical Model of Bone Angiosarcoma Patients: A Population-based Analysis of Epidemiology, Prognosis, and Treatment.
    Wang B; Chen LJ; Wang XY
    Orthop Surg; 2020 Dec; 12(6):1652-1662. PubMed ID: 32914587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The novel prognostic nomograms for predicting cancer-specific survival and overall survival in mixed medullary and follicular cell carcinoma: A SEER-based study.
    Li Y; Guo T; Gao X; Liu J
    J Cancer Res Clin Oncol; 2023 Dec; 149(18):16337-16354. PubMed ID: 37704803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparing the characteristics and predicting the survival of patients with head and neck melanoma versus body melanoma: a population-based study.
    Ding Y; Jiang R; Chen Y; Jing J; Yang X; Wu X; Zhang X; Xu J; Xu P; LiuHuang SC; Lu Z
    BMC Cancer; 2021 Apr; 21(1):420. PubMed ID: 33863315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Construction and validation of prognostic nomograms for elderly patients with metastatic non-small cell lung cancer.
    Sun H; Liu M; Yang X; Ren Y; Dai H; Wang C
    Clin Respir J; 2022 May; 16(5):380-393. PubMed ID: 35514033
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic Nomogram Based on the Metastatic Lymph Node Ratio for T
    Shi J; Liu S; Cao J; Shan S; Ren C; Zhang J; Wang Y
    Front Oncol; 2022; 12():899759. PubMed ID: 35574346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nomograms for Predicting Overall Survival and Cancer-Specific Survival of Young Patients with Epithelial Ovarian Cancer: Analysis Based on SEER Program.
    Gao J; Wang S; Li F; Xu H; Li X; Yan L; Zhu L
    Adv Ther; 2022 Jan; 39(1):257-285. PubMed ID: 34716558
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Do patients with metastatic renal cell carcinoma obtain survival benefits from cytoreductive nephrectomy? A population-based study.
    Luo Z; Jiao B; Xu Q; He W; Zhao H; Liu Y; Chen H; Guan Y; Zhang G; Jiang Z
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):9657-9670. PubMed ID: 37231275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nomograms for predicting the overall and cancer-specific survival of patients with classical Hodgkin lymphoma: a SEER-based study.
    Zhang Y; Zhang J; Zeng H; Zhou XH; Zhou HB
    Oncotarget; 2017 Nov; 8(54):92978-92988. PubMed ID: 29190971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Establishment and validation of prognostic nomograms to predict overall survival and cancer-specific survival for patients with osteosarcoma.
    Yang QK; Lai QY; Wang Y; Wang Y; Yao ZX; Zhang XJ
    Neoplasma; 2021 Mar; 68(2):434-446. PubMed ID: 33118831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic Nomograms for Patients With NF-Pan-NET After Pancreatectomy: A Retrospective Analysis Based on SEER Database.
    Wang Y; Kong Y; Yang Q; Zhou D
    Cancer Rep (Hoboken); 2024 Sep; 7(9):e2165. PubMed ID: 39234666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic Nomograms for Predicting Overall Survival and Cancer-Specific Survival of Patients With Malignant Pheochromocytoma and Paraganglioma.
    Zheng L; Gu Y; Silang J; Wang J; Luo F; Zhang B; Li C; Wang F
    Front Endocrinol (Lausanne); 2021; 12():684668. PubMed ID: 34234744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.